Cargando…
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
BACKGROUND: Genomic copy number alterations commonly occur in prostate cancer and are one measure of genomic instability. The clinical implication of copy number change in advanced prostate cancer, which defines a wide spectrum of disease from high-risk localised to metastatic, is unknown. METHODS:...
Autores principales: | Grist, Emily, Friedrich, Stefanie, Brawley, Christopher, Mendes, Larissa, Parry, Marina, Ali, Adnan, Haran, Aine, Hoyle, Alex, Gilson, Claire, Lall, Sharanpreet, Zakka, Leila, Bautista, Carla, Landless, Alex, Nowakowska, Karolina, Wingate, Anna, Wetterskog, Daniel, Hasan, A. M. Mahedi, Akato, Nafisah B., Richmond, Malissa, Ishaq, Sofeya, Matthews, Nik, Hamid, Anis A., Sweeney, Christopher J., Sydes, Matthew R., Berney, Daniel M., Lise, Stefano, Parmar, Mahesh K. B., Clarke, Noel W., James, Nicholas D., Cremaschi, Paolo, Brown, Louise C., Attard, Gerhardt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442998/ https://www.ncbi.nlm.nih.gov/pubmed/36059000 http://dx.doi.org/10.1186/s13073-022-01080-4 |
Ejemplares similares
-
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial
por: Parry, Marina A., et al.
Publicado: (2023) -
Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021) -
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
por: Hasan, A. M. Mahedi, et al.
Publicado: (2023) -
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
por: Ali, Adnan, et al.
Publicado: (2020) -
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)